These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
616 related articles for article (PubMed ID: 26216710)
1. Tumor infiltrating immune cells in gliomas and meningiomas. Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710 [TBL] [Abstract][Full Text] [Related]
2. The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells. Fang L; Lowther DE; Meizlish ML; Anderson RC; Bruce JN; Devine L; Huttner AJ; Kleinstein SH; Lee JY; Stern JN; Yaari G; Lovato L; Cronk KM; O'Connor KC Neuro Oncol; 2013 Nov; 15(11):1479-90. PubMed ID: 23978377 [TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas. Domingues PH; Teodósio C; Ortiz J; Sousa P; Otero A; Maillo A; Bárcena P; García-Macias MC; Lopes MC; de Oliveira C; Orfao A; Tabernero MD Am J Pathol; 2012 Nov; 181(5):1749-61. PubMed ID: 22982440 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory infiltrates and natural killer cell presence in human brain tumors. Stevens A; Klöter I; Roggendorf W Cancer; 1988 Feb; 61(4):738-43. PubMed ID: 3338036 [TBL] [Abstract][Full Text] [Related]
5. Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations. Kataki A; Skandami V; Memos N; Nikolopoulou M; Oikonomou V; Androulis A; Konstadoulakis MM; Zografos CG J Neurosurg Sci; 2014 Mar; 58(1):9-15. PubMed ID: 24614787 [TBL] [Abstract][Full Text] [Related]
6. Association between inflammatory infiltrates and isolated monosomy 22/del(22q) in meningiomas. Domingues PH; Teodósio C; Otero Á; Sousa P; Ortiz J; Macias Mdel C; Gonçalves JM; Nieto AB; Lopes MC; de Oliveira C; Orfao A; Tabernero MD PLoS One; 2013; 8(10):e74798. PubMed ID: 24098347 [TBL] [Abstract][Full Text] [Related]
7. Association Between Interleukin-10 Receptors and the CD45-Immunophenotype of Central Nervous System Tumors: A Preliminary Study. Zadka L; Kram P; Koscinski J; Jankowski R; Kaczmarek M; Piatek K; Kulus M; Gomułkiewicz A; Piotrowska A; Dziegiel P Anticancer Res; 2017 Oct; 37(10):5777-5783. PubMed ID: 28982901 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma. Du Z; Abedalthagafi M; Aizer AA; McHenry AR; Sun HH; Bray MA; Viramontes O; Machaidze R; Brastianos PK; Reardon DA; Dunn IF; Freeman GJ; Ligon KL; Carpenter AE; Alexander BM; Agar NY; Rodig SJ; Bradshaw EM; Santagata S Oncotarget; 2015 Mar; 6(7):4704-16. PubMed ID: 25609200 [TBL] [Abstract][Full Text] [Related]
11. Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors. El Andaloussi A; Han Y; Lesniak MS J Neurosurg; 2006 Sep; 105(3):430-7. PubMed ID: 16961139 [TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical study of the cellular immune response in meningiomas. Rossi ML; Cruz Sanchez F; Hughes JT; Esiri MM; Coakham HB J Clin Pathol; 1988 Mar; 41(3):314-9. PubMed ID: 3258871 [TBL] [Abstract][Full Text] [Related]
13. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. Morantz RA; Wood GW; Foster M; Clark M; Gollahon K J Neurosurg; 1979 Mar; 50(3):305-11. PubMed ID: 422981 [TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas. Tsuyuguchi N Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343 [TBL] [Abstract][Full Text] [Related]
15. Characterization of immune cell infiltration into canine intracranial meningiomas. Boozer LB; Davis TW; Borst LB; Zseltvay KM; Olby NJ; Mariani CL Vet Pathol; 2012 Sep; 49(5):784-95. PubMed ID: 21987303 [TBL] [Abstract][Full Text] [Related]
16. Dynamics of central and peripheral immunomodulation in a murine glioma model. Kennedy BC; Maier LM; D'Amico R; Mandigo CE; Fontana EJ; Waziri A; Assanah MC; Canoll P; Anderson RC; Anderson DE; Bruce JN BMC Immunol; 2009 Feb; 10():11. PubMed ID: 19226468 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma. Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730 [TBL] [Abstract][Full Text] [Related]
18. Immune microenvironment of gliomas. Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634 [TBL] [Abstract][Full Text] [Related]
19. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas. Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034 [TBL] [Abstract][Full Text] [Related]
20. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Badie B; Schartner JM Neurosurgery; 2000 Apr; 46(4):957-61; discussion 961-2. PubMed ID: 10764271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]